Additional information
| Active substance | Paliperidone |
|---|---|
| Classification | Antipsychotic |
| Acne | No |
| Water Retention | No |
| HBR | No |
| Hepatotoxicity | No |
| Aromatization | No |
| Lab Test | Monitoring plasma levels not typically required but may be performed to ensure therapeutic levels |
| Also known as | Paliperidone |
| WAREHOUSE | International Warehouse 2 |
| Blood pressure | Can cause orthostatic hypotension |
| Trade name | Invega |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | 9-hydroxyrisperidone |
| Formula | C23H27FN4O3 |
| Substance class | Atypical antipsychotic |
| Main action | Antagonist of serotonin type 2 (5HT2) and dopamine type 2 (D2) receptors |
| Half-life | Approximately 23 hours |
| Dosage (medical) | Typically starts at 3 mg per day, can be adjusted up to 12 mg per day based on clinical response |
| Dosage (sports) | Not applicable |
| Effects | Symptom reduction in schizophrenia and schizoaffective disorder |
| Side effects | Extrapyramidal symptoms (EPS), tachycardia, weight gain, dizziness, insomnia, constipation |
| Use in sports | None |
| Manufacturer | Janssen-Cilag |
Seretide Disckus (Advair) 500 mcg Glaxosmithkline
Fostimon (Merional) 150 IU HMG IBSA
Champix 56 tabs Pfizer
Fostimon (Merional) 75 (HMG) IBSA
FACTIVE 320 mg Abdi Ibragim
Bvs Labs Testosteron Cypionat 250 mg 10 ml
DELETE - Micardis 80 mg Boehringer Ingelheim 

Reviews
There are no reviews yet.